<DOC>
	<DOCNO>NCT02115360</DOCNO>
	<brief_summary>A prospective randomize double-blind clinical trial design use cohort sixty patient gender , physical status American Society Anaesthesiologist ( ASA ) I II undergo low limb amputation , enrol present study . Patients divide randomly two equal group : Epidural Bupivacain-Calcitonin fentanyl ( BC ) Group Bupivacain- fentanyl ( BF ) Group , comprise 30 patient .</brief_summary>
	<brief_title>Epidural Calcitonin Lower Limb Amputation</brief_title>
	<detailed_description>cohort sixty patient gender , physical status American Society Anaesthesiologist ( ASA ) I II undergo low limb amputation , enrol present study . Patients divide randomly two equal group : Epidural Bupivacain-Calcitonin fentanyl ( BC ) Group Bupivacain- fentanyl ( BF ) Group , comprise 30 patient .</detailed_description>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Lidocaine</mesh_term>
	<mesh_term>Bupivacaine</mesh_term>
	<mesh_term>Fentanyl</mesh_term>
	<mesh_term>Epinephrine</mesh_term>
	<mesh_term>Racepinephrine</mesh_term>
	<mesh_term>Epinephryl borate</mesh_term>
	<mesh_term>Salmon calcitonin</mesh_term>
	<mesh_term>Calcitonin</mesh_term>
	<mesh_term>Calcitonin Gene-Related Peptide</mesh_term>
	<criteria>prospective randomize doubleblind clinical trial design use cohort sixty patient gender physical status American Society Anaesthesiologist ( ASA ) I II undergo low limb amputation history pituitary gland dysfunction cardiac disease chronic obstructive respiratory disease contraindication perform epidural block : coagulation abnormality spinal deformity , patient allergic local anesthetic calcitonin exclude study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>epidural calcitonin</keyword>
	<keyword>amputation</keyword>
	<keyword>postoperative pain</keyword>
	<keyword>Later Complication</keyword>
</DOC>